Shamrax Pharmaceuticals Private Limited
About Shamrax Pharmaceuticals Private Limited
Data last updated:
Shamrax Pharmaceuticals Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 14 August 2024.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U21002PN2024PTC233585.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹50,000. It is led by directors Ratnaprabha Sunil Patil and Shyamal Pandurang Jamdar.
Its last annual general meeting (AGM) was held on 31 December 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Pune, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹13.45 Lakh. For the same year it recorded a net loss of ₹15,811 (net margin -1.2%) and EBITDA of -₹15,811 (EBITDA margin -1.2%).
As per MCA filings, the company has open charges of ₹7 Lakh on record.
Company details
Contact details
Shamrax Pharmaceuticals Private Limited's registered office is in Pune, Maharashtra.
- Registered AddressWonder Futura Sno. 71, Kothrud Near Wonder Fun M, Pune, Maharashtra, India – 411038
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Shamrax Pharmaceuticals Private Limited
FY 2025 filings availableShamrax Pharmaceuticals Private Limited reported revenue of ₹13.45 Lakh for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | -₹15,811 |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | -₹15,811 |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2024-25 |
|---|---|
| Profitability | |
| EBITDA Margin | -1.2% |
| Net Profit Margin | -1.2% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Shamrax Pharmaceuticals Private Limited, buy the company report.
Board of directors of Shamrax Pharmaceuticals Private Limited
Shamrax Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ratnaprabha Sunil Patil | Director | 14 Aug 2024 | 2 Years 2 Months | Current |
| Shyamal Pandurang Jamdar | Director | 14 Aug 2024 | 2 Years 2 Months | Current |
Peer comparison
Shamrax Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ryokona Pharmaceuticals Private Limited | ₹13.59 Lakh (FY 2025) | -34.0% | Gorakhpur, Uttar Pradesh, India | |||
| Sangie Pharmaceuticals Private Limited | ₹13.57 Lakh (FY 2025) | -80.0% | Thane, Maharashtra, India | |||
| Miron Pharmaceuticals Private Limited | ₹13.5 Lakh (FY 2024) | 15.0% | Nellore, Andhra Pradesh, India | |||
| Nextone Pharmaceuticals Private Limited | ₹13.5 Lakh (FY 2024) | 65.0% | Lucknow, Uttar Pradesh, India | |||
| P.G.H Pharmaceuticals India Private Limited | ₹13.49 Lakh (FY 2025) | -16.0% | Mathura, Uttar Pradesh, India | |||
| Shamrax Pharmaceuticals Private Limitedthis company | ₹13.45 Lakh (FY 2025) | -₹15,811 | -1.2% | Pune, Maharashtra, India | ||
| Astrio Pharmaceuticals Private Limited | ₹13.45 Lakh (FY 2020) | Katrap, Maharashtra, India | ||||
| Archimed Pharmaceuticals Private Limited | ₹13.4 Lakh (FY 2025) | -6.0% | Bareilly, Uttar Pradesh, India | |||
| Shasha Pharmaceuticals Private Limited | ₹13.39 Lakh (FY 2025) | 128.0% | Delhi, India | |||
| Rightmed Pharmaceuticals Private Limited | ₹13.38 Lakh (FY 2020) | 239.0% | Perinthalmanna, Kerala, India | |||
| Pandora Pharmaceuticals Private Limited | ₹13.38 Lakh (FY 2025) | 7.0% | Shahdol, Madhya Pradesh, India |
To see the full peer comparison of Shamrax Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 14 Jul 2025 | 101139304 | State Bank of India | ₹7 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Shamrax Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Shamrax Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Shamrax Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Shamrax Pharmaceuticals Private Limited has 2 board changes on record since 2024: 2 appointments. The latest: Ratnaprabha Sunil Patil was appointed as Director on 14 Aug 2024.
Frequently asked questions
Shamrax Pharmaceuticals is an active private limited company based in Pune, Maharashtra, India. The company works in paper and paper products, within the paper industry. It was incorporated on 14 August 2024 (2+ years old) and is registered under CIN U21002PN2024PTC233585.
Shamrax Pharmaceuticals has 2 current directors:
- Ratnaprabha Sunil Patil - Director
- Shyamal Pandurang Jamdar - Director
The latest financial statements of Shamrax Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 December 2025. Year-wise statements from FY 2025 are in the company report.
The CIN (Corporate Identification Number) of Shamrax Pharmaceuticals is U21002PN2024PTC233585. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Shamrax Pharmaceuticals was incorporated on 14 August 2024, making it 2+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Shamrax Pharmaceuticals by revenue are Ryokona Pharmaceuticals Private Limited, Sangie Pharmaceuticals Private Limited, Miron Pharmaceuticals Private Limited, Nextone Pharmaceuticals Private Limited, P.G.H Pharmaceuticals India Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Ratnaprabha Sunil Patil was appointed as Director on 14 Aug 2024. Shyamal Pandurang Jamdar was appointed as Director on 14 Aug 2024.
The registered office of Shamrax Pharmaceuticals is at Wonder Futura Sno. 71, Kothrud Near Wonder Fun M, Pune, Maharashtra, India – 411038.
Shamrax Pharmaceuticals operates in the paper industry, in the paper and paper products segment.
Shamrax Pharmaceuticals has open charges of ₹7 Lakh and no satisfied charges on record as per latest MCA filings.
Shamrax Pharmaceuticals can be reached at its registered office: Wonder Futura Sno. 71, Kothrud Near Wonder Fun M, Pune, Maharashtra, India – 411038.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
